{"id":195326,"date":"2015-03-26T05:46:33","date_gmt":"2015-03-26T09:46:33","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/university-and-biotech-firm-team-up-on-colorblindness-therapy.php"},"modified":"2015-03-26T05:46:33","modified_gmt":"2015-03-26T09:46:33","slug":"university-and-biotech-firm-team-up-on-colorblindness-therapy","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/gene-therapy\/university-and-biotech-firm-team-up-on-colorblindness-therapy.php","title":{"rendered":"University And Biotech Firm Team Up On Colorblindness Therapy"},"content":{"rendered":"<p><p>          A simulation from the Neitz lab of what colorblindness          looks like, with normal color vision on the left and          red-green colorblindness on the right. Courtesy of Neitz Laboratory hide caption        <\/p>\n<p>          A simulation from the Neitz lab of what colorblindness          looks like, with normal color vision on the left and          red-green colorblindness on the right.        <\/p>\n<p>    More than 10 million Americans have trouble distinguishing red    from green or blue from yellow, and there's no treatment for    colorblindness.  <\/p>\n<p>    A biotech company and two scientists hope to change that.  <\/p>\n<p>    On Wednesday, Avalanche Biotechnologies in Menlo Park and the    University of Washington in Seattle     announced a licensing agreement to develop the first    treatment for colorblindness. The deal brings together a gene    therapy technique developed by Avalanche with the expertise of    vision researchers at the University of Washington.  <\/p>\n<p>    \"Our goal is to be treating colorblindness in clinical trials    in patients in the next one to two years,\" says     Thomas Chalberg, the founder and CEO of Avalanche.  <\/p>\n<p>          Dalton the squirrel monkey during the color vision test.          Courtesy of Neitz Laboratory          hide caption        <\/p>\n<p>          Dalton the squirrel monkey during the color vision test.        <\/p>\n<p>    The agreement has its roots in a scientific breakthrough that    occurred six years ago. That's when two vision researchers at    the University of Washington used gene therapy to     cure a common form of colorblindness in squirrel monkeys.  <\/p>\n<p>    \"This opened the possibility of ultimately getting this to cure    colorblindness in humans,\" says     Jay Neitz, who runs the Color Vision    Lab at UW along with his wife,     Maureen Neitz.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>More: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.npr.org\/blogs\/health\/2015\/03\/25\/395303785\/university-and-biotech-firm-team-up-on-colorblindness-therapy?utm_medium=RSS&utm_campaign=science\/RK=0\/RS=KV9n.3c4PTE._Tt7J3cNQuoWg50-\" title=\"University And Biotech Firm Team Up On Colorblindness Therapy\">University And Biotech Firm Team Up On Colorblindness Therapy<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> A simulation from the Neitz lab of what colorblindness looks like, with normal color vision on the left and red-green colorblindness on the right. Courtesy of Neitz Laboratory hide caption A simulation from the Neitz lab of what colorblindness looks like, with normal color vision on the left and red-green colorblindness on the right <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/gene-therapy\/university-and-biotech-firm-team-up-on-colorblindness-therapy.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[24],"tags":[],"class_list":["post-195326","post","type-post","status-publish","format-standard","hentry","category-gene-therapy"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/195326"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=195326"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/195326\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=195326"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=195326"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=195326"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}